HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

South East Asia Microbial Transglutaminase Market Size & Outlook, 2025-2033


South East Asia Microbial Transglutaminase Market Insights

  • According to Reed Intelligence analysis, the South East Asia Microbial Transglutaminase Market size was USD 4.09 Million in 2024 and is projected to reach USD 9.61 Million by 2033.
  • The South East Asia market is projected to grow at a CAGR of 9.86% between 2026 and 2033.
  • By segment, Streptomyces Mobaraense emerged as the largest By Source in terms of market size in 2024.
  • Streptoverticillium Griseocarneum is anticipated to remain the most attractive By Source segment, recording the fastest growth during the forecast period.

Other Key Findings


  • South East Asia accounted for 3% of the global Microbial Transglutaminase Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional Microbial Transglutaminase Market size by 2033.
  • China will be the fastest-growing market in Asia Pacific, projected to achieve USD 36.3 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 4.09 Million
Market Size In 2033 USD 9.61 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 9.86% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports